Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149547 | PMC |
| http://dx.doi.org/10.1016/j.ajoc.2025.102356 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the treatment of ocular juvenile xanthogranuloma.
Arch Soc Esp Oftalmol (Engl Ed)
August 2025
Servicio de Oftalmología, Hospital Universitario La Paz, Madrid, Spain.
This is the case of a 14-years-old woman referred to our ophthalmology department with suspected iris juvenile xanthogranuloma, with reported bilateral, hematic recurrent uveitis as soon as she discontinued treatment with topical prednisolone acetate eye drops. After numerous treatments at the 3-year follow-up, including oral steroids, repeated injections of subtenon triamcinolone acetonide and intracameral and intravitreal anti-VEGF, treatment with intravitreal fluocinolone acetonide implant (ILUVIEN®) in both eyes was decided. Evolution since then and at the 10-month follow-up has been satisfactory; the patient has not exhibited any new episodes of ocular inflammation or hyphema despite the progressive withdrawal of topical corticosteroids, and vision has remained at 20/20 in both eyes.
View Article and Find Full Text PDFRecurrence of Intraocular Inflammation Following an Aflibercept 8-mg Injection in Eyes With a History of Intraocular Inflammation From Faricimab: A Case Report.
Cureus
June 2025
Department of Ophthalmology, University of Yamanashi, Chuo, JPN.
Vascular endothelial growth factor (VEGF) is critical in various retinal diseases. VEGF inhibitors are a standard treatment for neovascular age-related macular degeneration (AMD). However, intraocular inflammation (IOI) is a major complication after intravitreal administration of second-generation VEGF inhibitors.
View Article and Find Full Text PDFA Case of Persistent Bilateral Irvine-Gass Syndrome Following Uneventful Cataract Surgery in a Healthy Individual.
Cureus
June 2025
Ophthalmology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, MYS.
Pseudophakic cystoid macular edema (PCME), also known as Irvine-Gass Syndrome, is one of the most common causes of postoperative visual impairment, which is usually self-limiting in nature. We report a case of persistent bilateral Irvine-Gass Syndrome (IGS) up to 11 months in a healthy individual despite an uneventful cataract surgery. A 58-year-old e-hailing male driver without any underlying systemic comorbidities complained of cloudy vision six weeks after uneventful bilateral cataract surgery.
View Article and Find Full Text PDFThe impact of epiretinal membrane stage and postoperative treatment on visual and anatomical outcomes following vitrectomy in eyes with preexisting macular edema.
Int J Retina Vitreous
July 2025
Department of Ophthalmology, University Hospital Ulm, Prittwitzstr. 43 , D-89075, Ulm, Germany.
Backround: Idiopathic epiretinal membrane (iERM) is often associated with different types of macular edema (ME). This study aimed to evaluate the impact of iERM stage and postoperative treatment on visual and anatomical outcomes after pars plana vitrectomy (PPV) with peeling in eyes with iERM and treatment-naïve pre-existing ME.
Methods: This retrospective analysis included eyes with iERM and different preexisting ME (microcystic = MME, cystoid = CME or combined ME) that underwent PPV with iERM and ILM-peeling and were followed for 12 months.
A case of refractory idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN) responsive to infliximab and mycophenolate mofetil.
Retin Cases Brief Rep
June 2025
Department of Ophthalmology, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Purpose: Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a severe vision-threatening retinal vascular inflammatory disease. As a very rare condition, more reports of cases are needed to better guide diagnosis and management. We report a case of IRVAN initially refractory to adalimumab, rituximab, oral corticosteroids, subtenon triamcinolone injection, and intravitreal bevacizumab therapy that was successfully treated with infliximab and mycophenolate mofetil.
View Article and Find Full Text PDF